Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse, Mantle Cell Lymphoma, Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04830137
What this trial is testing

NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Waldenstrom Macroglobulinemia (WM)+5 more
Nurix Therapeutics, Inc. 248
Not applicableLooking for participantsNCT06339255
What this trial is testing

Italian Observational Study on CAR-T Therapy for Lymphoma

Who this might be right for
Diffuse Low Grade B-Cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma+1 more
Paolo Corradini 5,300
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003874
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Study completedNCT00807495
What this trial is testing

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Diffuse Large B-cell LymphomaMantle Cell LymphomaBurkitt's Lymphoma+2 more
Millennium Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT04279405
What this trial is testing

A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies

Who this might be right for
Small Lymphocytic LymphomaLymphoplasmacytic LymphomaMarginal Zone Lymphoma+2 more
Shanghai YingLi Pharmaceutical Co. Ltd. 43
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT04282018
What this trial is testing

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaFollicular Lymphoma+4 more
BeiGene 97
Not applicableStudy completedNCT00896662
What this trial is testing

Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT02978235
What this trial is testing

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaNonHodgkin Lymphoma
Taiho Oncology, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT01118845
What this trial is testing

Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, Large CellDiffuse, Mantle Cell Lymphoma, Lymphoma+2 more
SymBio Pharmaceuticals 63
Not applicableNot Yet RecruitingNCT07412405
What this trial is testing

This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R

Who this might be right for
Adult B-cell Acute Lymphoblastic LeukemiaFollicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)+2 more
GUSTAVO SALGUERO 12
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Testing effectiveness (Phase 2)Study completedNCT00474929
What this trial is testing

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 103
Testing effectiveness (Phase 2)Study completedNCT01827579
What this trial is testing

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

Who this might be right for
Haematological Malignancies
University College, London 37
Testing effectiveness (Phase 2)Study completedNCT00992446
What this trial is testing

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Next Page